For GLP-1 analogues, DPP-4 inhibitors and insulin, the changes in the two study groups were similar, and the differences did not reach statistical significance ( Table 2 ).
← all excerpts
Academic detailing as a method to improve general practitioners' drug prescribing in type 2 diabetes: evaluation of changes in prescribing.
1
—
—